DOI QR코드

DOI QR Code

Association between the Metabolic Syndrome and High Tumor Grade and Stage of Primary Urothelial Cell Carcinoma of the Bladder

  • Ozbek, Emin (Okmeydani Training and Research Hospital Department of Urology) ;
  • Otunctemur, Alper (Okmeydani Training and Research Hospital Department of Urology) ;
  • Dursun, Murat (Okmeydani Training and Research Hospital Department of Urology) ;
  • Koklu, Ismail (Okmeydani Training and Research Hospital Department of Urology) ;
  • Sahin, Suleyman (Okmeydani Training and Research Hospital Department of Urology) ;
  • Besiroglu, Huseyin (Okmeydani Training and Research Hospital Department of Urology) ;
  • Erkoc, Mustafa (Okmeydani Training and Research Hospital Department of Urology) ;
  • Danis, Eyyup (Okmeydani Training and Research Hospital Department of Urology) ;
  • Bozkurt, Muammer (Okmeydani Training and Research Hospital Department of Urology)
  • Published : 2014.02.01

Abstract

Purpose: To compare histopathologic findings of patients who underwent transurethral resection of a bladder tumor (TUR-B) between groups with and without the metabolic syndrome. Materials and Methods: We retrospectively analyzed data of 535 patients who underwent TUR-B in our department between October 2005 and March 2011. All patients had primary urethelial cell carcinoma (UCB). Histologic stage, grade, the presence of hypertension, diabetes mellitus, body mass index (BMI), waist circumference, HDL and trigliseride levels were evaluated. The TNM classification was used, with Ta tumor accepted as lower stage and T1 and T2 tumors as higher stage bladder cancers. Also, the pathological grading adopted by the 2004 World Health Organization grading system were applied. Non-invasive papillary urothelial neoplasms of low malignant potential were regarded as low grade. Results: Among the total of 509 patients analyzed in our study, there were 439 males (86.2%) and 70 females (13.8%). Metabolic syndrome was significantly associated with high histologic grade, and high pathologic stage (p<0.001). Conclusions: The patients with metabolic syndrome were found to have statistically significant higher T stage and grade of bladder cancer. Further studies with more patients are needed to confirm our study.

Keywords

References

  1. Batty GD, Shipley MJ, Jarrett RJ, et al (2005). Obesity and overweight in relation to organ-specific cancer mortality in London (UK): findings from the original Whitehall study. Int J Obes, 29, 1267-74. https://doi.org/10.1038/sj.ijo.0803020
  2. Borena W, Strohmaier S, Lukanova A, et al (2011). Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults. Int J Cancer, 43, 1-25.
  3. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003). Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med, 348, 1625-38. https://doi.org/10.1056/NEJMoa021423
  4. Chen HS, Su LT, Lin SZ, et al (2012). Increased risk of urinary tract calculi among patients with diabetes mellitus - a population-based cohort study. Urology, 79, 86-92. https://doi.org/10.1016/j.urology.2011.07.1431
  5. Chow WH, Lindblad P, Gridley G, et al (1997). Risk of urinary tract cancers following kidney or ureter stones. J Natl Cancer Inst, 89, 1453-7. https://doi.org/10.1093/jnci/89.19.1453
  6. Cowey S, Hardy RW (2006). The metabolic syndrome: A highrisk state for cancer? Am J Pathol, 169, 1505-22. https://doi.org/10.2353/ajpath.2006.051090
  7. Currie CJ, Poole CD, Jenkins-Jones S, et al (2012). Mortality After Incident Cancer in People With and Without Type 2 Diabetes: Impact of metformin on survival. Diabetes Care, 35, 299-304. https://doi.org/10.2337/dc11-1313
  8. Dunn SE1, Kari FW, French J, et al (1997). Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice. Cancer Res, 57, 4667-72.
  9. Eckel RH (2007). Treating dyslipidemia of the metabolic syndrome: where's the evidence? Nat Clin Pract Endocrinol Metab, 3, 437. https://doi.org/10.1038/ncpendmet0514
  10. Freedman ND, Silverman DT, Hollenbeck AR, Schatzkin A, Abnet CC (2011). Association between smoking and risk of bladder cancer among men and women. JAMA, 306, 737-45. https://doi.org/10.1001/jama.2011.1142
  11. Funfstuck R, Nicolle LE, Hanefeld M, Naber KG (2012). Urinary tract infection in patients with diabetes mellitus. Clin Nephrol, 77, 40-8. https://doi.org/10.5414/CN107216
  12. Gorbachinsky I, Akpinar H, Assimos DG (2010). Metabolic syndrome and urologic diseases. Rev Urol, 12, 157-80.
  13. Grove JS, Nomura A, Severson RK, Stemmermann GN (1991). The association of blood Pressure with cancer incidence in a prospective Study. Am J Epidemiol, 134, 942-7.
  14. Haggstrom C, Stocks T, Rapp K, et al (2011). Metabolic syndrome and risk of bladder cancer: prospective cohort study in the metabolic syndrome and cancer project (Me-Can). International journal of cancer. Journal international du cancer, 128, 1890-8. https://doi.org/10.1002/ijc.25521
  15. Hiatt RA, Fireman BH (1986). Serum cholesterol and the incidence of cancer in a large cohort. J Chronic Dis, 39, 861-70. https://doi.org/10.1016/0021-9681(86)90034-2
  16. Hole DJ, Hawthorne VM, Isles CG, et al (1993). Incidence of and mortality from cancer in hypertensive patients. BMJ, 306, 609-11 https://doi.org/10.1136/bmj.306.6878.609
  17. Holick CN, Giovannucci EL, Stampfer MJ, Michaud DS (2007). Prospective study of body mass index, height, physical activity and incidence of bladder cancer in US men and women. Int J Cancer, 120, 140-6. https://doi.org/10.1002/ijc.22142
  18. Hu J, La Vecchia C, de Groh M, et al (2012). Dietary cholesterol intake and cancer. Ann Oncol, 23, 491-500. https://doi.org/10.1093/annonc/mdr155
  19. Jankovic S, Radosavljevic V (2007). Risk factors for bladder cancer. Tumori, 93, 4-12.
  20. Jee SH, Yun JE, Park EJ, et al (2008). Body mass index and cancer risk in Korean men and women. Int J Cancer, 123, 1892-6. https://doi.org/10.1002/ijc.23719
  21. Jee SH, Ohrr H, Sull JW, et al (2005). Fasting serum glucose level and cancer risk in Korean men and women. JAMA, 293, 194-202. https://doi.org/10.1001/jama.293.2.194
  22. Koebnick C, Michaud D, Moore SC, et al (2008). Body mass index, physical activity, and bladder cancer in a large prospective study. Cancer Epidemiol Biomarkers Prev, 17, 1214-21. https://doi.org/10.1158/1055-9965.EPI-08-0026
  23. Larsson SC, Andersson SO, Johansson JE, Wolk A (2008). Diabetes mellitus, body size and bladder cancer risk in a prospective study of Swedish men. Eur J Cancer, 44, 2655-60. https://doi.org/10.1016/j.ejca.2008.07.012
  24. Lee MY, Lin KD, Hsiao PJ, Shin SJ (2012). The association of diabetes mellitus with liver, colon, lung, and prostate cancer is independent of hypertension, hyperlipidemia, and gout in Taiwanese patients. Metabolism, 61, 242-9. https://doi.org/10.1016/j.metabol.2011.06.020
  25. Li N, Yang L, Zhang Y, et al (2011). Human papillomavirus infection and bladder cancer risk: a meta-analysis. J Infect Dis, 204, 217-23. https://doi.org/10.1093/infdis/jir248
  26. Liu X, Ji J, Sundquist K, Sundquist J, Hemminki K (2012). The impact of type 2 diabetes mellitus on cancer-specific survival: a follow-up study in Sweden. Cancer, 118, 1353-61. https://doi.org/10.1002/cncr.26420
  27. Murta-Nascimento C, Schmitz-Drager BJ, Zeegers MP, et al (2007). Epidemiology of urinary bladder cancer: from tumor development to patient's death. World J Urol, 25, 285-95. https://doi.org/10.1007/s00345-007-0168-5
  28. Qin Q, Xu X, Wang X, et al (2013). Obesity and risk of bladder cancer: a meta-analysis of cohort studies. Asian Pac J Cancer Prev, 14, 3117-21. https://doi.org/10.7314/APJCP.2013.14.5.3117
  29. Reeves GK, Pirie K, Beral V, et al (2007). Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ, 335, 1134. https://doi.org/10.1136/bmj.39367.495995.AE
  30. Rosengren A, Himmelmann A, Wilhelmsen L, Branehog I, Wedel H (1998). Hypertension and long-term cancer incidence and mortality among Swedish men. J Hypertens, 16, 933-40. https://doi.org/10.1097/00004872-199816070-00006
  31. Samanic C, Gridley G, Chow WH, et al (2004). Obesity and cancer risk among white and black United States veterans. Cancer Causes Control, 15, 35-43. https://doi.org/10.1023/B:CACO.0000016573.79453.ba
  32. Samanic C, Chow WH, Gridley G, Jarvholm B, Fraumeni JF Jr (2006). Relation of body mass index to cancer risk in 362,552 Swedish men. Cancer Causes Control, 17, 901-9. https://doi.org/10.1007/s10552-006-0023-9
  33. Siegel R, Naishadham D, Jemal A (2012). Cancer statistics, 2012. CA: A Cancer J Clin, 62, 10-29. https://doi.org/10.3322/caac.20138
  34. Stocks T, Rapp K, Bjorge T, Manjer J, Ulmer H (2009). Blood glucose and risk of incident and fatal cancer in the metabolic syndrome and cancer project (me-can): analysis of six prospective cohorts. PLoS Med, 6, 1000201. https://doi.org/10.1371/journal.pmed.1000201
  35. Stumpe KO (2002). Hypertension and the risk of cancer: is there new evidence? J Hypertens, 20, 565-7. https://doi.org/10.1097/00004872-200204000-00003
  36. Yang XQ, Xu C, Sun Y, Han RF (2013). Diabetes mellitus increases the risk of bladder cancer: an updated meta-analysis. Asian Pac J Cancer Prev, 14, 2583-9. https://doi.org/10.7314/APJCP.2013.14.4.2583
  37. Zhao H, Grossman HB, Spitz MR, et al (2003). Plasma levels of insulin-like growth factor-1 and binding protein-3, and their association with bladder cancer risk. J Urol, 169, 714-7. https://doi.org/10.1016/S0022-5347(05)63999-7

Cited by

  1. Diabetes Mellitus as a Risk Factor for High Grade Renal Cell Carcinoma vol.15, pp.9, 2014, https://doi.org/10.7314/APJCP.2014.15.9.3993
  2. The Metabolic Syndrome is Associated with More Aggressive Prostate Cancer vol.15, pp.9, 2014, https://doi.org/10.7314/APJCP.2014.15.9.4029
  3. The association between metabolic syndrome and the risk of urothelial carcinoma of the bladder: a case-control study in China vol.13, pp.1, 2015, https://doi.org/10.1186/s12957-015-0631-5
  4. Laparoscopic Retroperitoneal Nephroureterectomy is a Safe and Adherent Modality for Obese Patients with Upper Urinary Tract Urothelial Carcinoma vol.16, pp.8, 2015, https://doi.org/10.7314/APJCP.2015.16.8.3223